LH-Guided Recombinant LH Supplementation in Women Undergoing IVF/ICSI
NCT07933341, Completed, Stella Maris Women and Children Hospital
Trial 8
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | LH-Guided Recombinant LH Supplementation in Women Undergoing IVF/ICSI | ClinicalTrials.gov |
| NCT number | NCT07933341 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Enrollment | 395 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Stella Maris Women and Children Hospital | ClinicalTrials.gov |
| Conditions | Infertility, Infertility (IVF Patients), Infertility Assisted Reproductive Technology | ClinicalTrials.gov |
| First posted | 2026-11-12 | ClinicalTrials.gov |
| Last updated | 2026-11-12 | ClinicalTrials.gov |
Registered outcomes 2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Number of good-quality blastocysts per IVF/ICSI cycle | At blastocyst assessment, 5-6 days after oocyte retrieval | The primary outcome was the number of good-quality blastocysts obtained per IVF/ICSI cycle. Blastocyst quality was assessed using the Gardner grading system. Good-quality blastocysts were defined as blastocysts with an expansion grade of 4-6 and inner cell mass (ICM) and trophectoderm (TE) grades of AA, AB, or BA. The number of good-quality blastocysts per cycle was compared between women who received LH-guided recombinant LH supplementation and those who did not receive supplementation. | ClinicalTrials.gov |
| Secondary | Clinical pregnancy rate confirmed by transvaginal ultrasonography | Approximately 24 days after blastocyst transfer | The secondary outcome was the clinical pregnancy rate following IVF/ICSI treatment. Clinical pregnancy was defined as the ultrasonographic visualization of one or more gestational sacs. Serum beta-human chorionic gonadotropin (β-hCG) was measured 10 days after blastocyst transfer, followed by transvaginal ultrasonography approximately 2 weeks after biochemical pregnancy confirmation. The clinical pregnancy rate was calculated as the percentage of women with a confirmed clinical pregnancy among all women who underwent embryo transfer in each study group. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)